Valuation Zhuhai Rundu Pharmaceutical Co., Ltd.

Stocks

End-of-day quote Shenzhen S.E. Other stock markets 18/06/2026			5-day change	1st Jan Change
9.780 ^CNY	-0.20%		-2.88%	-19.51%

05-22	Zhuhai Rundu Pharmaceutical Wins China Approval for Pain Relief Drug	MT
05-19	China Grants Zhuhai Rundu Pharmaceutical Marketing Approval for Hypertension Drug	MT

Data adjusted to current consolidation scope

Fiscal Period: December	2019	2020	2021	2022	2023	2024
Market Cap ¹	3,228	2,999	4,552	4,186	4,133	3,195
Change	-	-7.11%	51.79%	-8.03%	-1.28%	-22.69%
Enterprise Value (EV) ¹	2,926	2,772	4,588	4,433	4,491	3,489
Change	-	-5.24%	65.48%	-3.37%	1.31%	-22.32%
P/E	27.2x	21.8x	32.2x	26.9x	61.7x	79.5x
PBR	3.43x	2.89x	4.09x	3.5x	3.5x	2.77x
PEG	-	1.4x	11.9x	2.4x	-1.1x	-2x
Capitalization / Revenue	2.37x	2.39x	3.83x	3.05x	3.2x	2.7x
EV / Revenue	2.15x	2.21x	3.86x	3.23x	3.48x	2.95x
EV / EBITDA	21.5x	15.6x	23.1x	18.8x	24.5x	20.1x
EV / EBIT	29.8x	21.8x	33.1x	26.7x	62.1x	88.3x
EV / FCF	-29.3x	-24.5x	-22.2x	-34.3x	-33.4x	27.7x
FCF Yield	-3.41%	-4.07%	-4.51%	-2.92%	-2.99%	3.61%
Dividend per Share ²	0.2198	0.2198	0.2198	0.25	0.2	0.15
Rate of return	2.3%	2.48%	1.63%	2%	1.62%	1.57%
EPS ²	0.3516	0.4066	0.4176	0.4643	0.2	0.12
Distribution rate	62.5%	54.1%	52.6%	53.8%	100%	125%
Net sales ¹	1,360	1,253	1,190	1,372	1,292	1,182
EBITDA ¹	135.9	177.3	198.4	235.5	183.2	173.3
EBIT ¹	98.31	127.3	138.5	166	72.31	39.52
Net income ¹	118.9	135.9	139.8	155.5	66.9	39.88
Net Debt ¹	-302.3	-226.3	36.22	247.3	358.9	294
Reference price ²	9.566	8.863	13.467	12.500	12.340	9.540
Nbr of stocks (in thousands)	337,463	338,359	337,992	334,893	334,893	334,893
Announcement Date	16/04/20	22/04/21	18/04/22	27/04/23	27/04/24	28/04/25

¹CNY in Million²CNY

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
ZHUHAI RUNDU PHARMACEUTICAL CO., LTD.	-	-	-	-	484M
ELI LILLY AND COMPANY	32.01x	11.69x	23.99x	0.62%	980B
JOHNSON & JOHNSON	24.41x	5.63x	15.32x	2.34%	550B
ABBVIE INC.	26.86x	6.49x	13.28x	3.17%	382B
ROCHE HOLDING AG	17.04x	4.24x	10.43x	3.13%	316B
ASTRAZENECA PLC	21.94x	4.59x	13.02x	1.91%	272B
NOVARTIS AG	20.28x	5.27x	12.78x	3.05%	268B
NOVO NORDISK A/S	13x	4.83x	9.94x	3.87%	199B
AMGEN INC.	21.95x	5.91x	10.33x	2.99%	182B
GILEAD SCIENCES, INC.	-44.34x	5.36x	29.54x	2.62%	154B
Average	14.79x	6.00x	15.40x	2.63%	330.28B
Weighted average by Cap.	21.68x	7.24x	16.85x	2.17%